Filing Details

Accession Number:
0001209191-17-028456
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-04-27 17:00:25
Reporting Period:
2017-04-20
Filing Date:
2017-04-27
Accepted Time:
2017-04-27 17:00:25
Original Submission Date:
2017-04-24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108205 Curis Inc CRIS Biological Products, (No Disgnostic Substances) (2836) 043505116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190126 R James Mcnab 4 Maguire Road
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-04-20 22,541 $2.66 1,057,147 No 4 S Direct
Common Stock Disposition 2017-04-21 45,705 $2.58 1,011,442 No 4 S Direct
Common Stock Disposition 2017-04-24 42,076 $2.56 969,366 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 300,000 Indirect By JR & MW McNab Operating LP
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.61 to $2.69, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  3. The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.65, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  4. The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.58, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.